BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

#advertisement

12th Aging Research & Drug Discovery Meeting

Latest News

UK Rolls Out National Strategy to Build …

UK Rolls Out National Strategy to Build Europe’s Life Sciences Powerhouse by 2030

The UK government has released a new Industrial Strategy white paper outlining plans to strengthen the country’s life sciences sector. Building on the previous green … Read More

Japan’s Elix Launches AI Drug Discovery Platform …

Japan’s Elix Launches AI Drug Discovery Platform Trained on Confidential Pharma Data via Federated Learning

Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on proprietary compound data from 16 … Read More

Google Expands MedGemma Collection With Multimodal Health …

Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development

Google Research has released two new models—MedGemma 27B Multimodal and MedSigLIP—as part of its open-source Health AI Developer Foundations (HAI-DEF) initiative, expanding the MedGemma suite … Read More

Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform

NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies

datma Launches Free Tool for Pharma to Assess Biomarker Coverage in Federated RWD

AbbVie Acquires Capstan Therapeutics for $2.1B, Gaining In Vivo CAR-T Platform Targeting Autoimmune Diseases

Chai Discovery Releases All-Atom Foundation Model for Zero-Shot Antibody Design with 16–20% Hit Rates

Arc Institute Opens Virtual Cell Challenge With $175K in AI Benchmarking Prizes

Read latest news ›››

Latest Insights

Novotech Report: Over 800 Global IPF Trials …

by BiopharmaTrend

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers … Read More

Into the Unknown — How Artificial Intelligence …

by Louise von Stechow

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding DNA—the so-called “dark genome” has … Read More

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

by Louise von Stechow

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

by Dominik Tomicevic

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

Read all insights ›››

From Our Partners

Read All ›››

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Patented AI Platform Identifies Promising Early-Stage BioPharma …

Sponsored by Intelligencia AI

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Partner Events

View all events ›››

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

The 12th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

Case Studies

Read All ›››

Application of AI-driven Xanthos Platform for Designing …

Sponsored by Celeris Therapeutics

Application of AI-driven Xanthos Platform for Designing Protein Degraders

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Bioz Badges — Advanced Data-Widgets for Confident …

Sponsored by Bioz

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Biocompare: Offline Order Attribution Analysis Helps Demonstrate …

Sponsored by Biocompare

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Interviews

Read All ›››

Pioneering the Largest Foundation Model to Transform …

Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey

The Synergistic Potential of AI and Synthetic …

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Turbocharging Phenotypic Screening with AI to Target …

Turbocharging Phenotypic Screening with AI to Target mRNA Biology

Most Read

Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, …

Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography

From Gene Editing to Pathway Design: How …

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

21 Life Science Marketplaces to Try in …

21 Life Science Marketplaces to Try in 2024

11 Notable Companies Enabling Decentralized Clinical Trials

11 Notable Companies Enabling Decentralized Clinical Trials